Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-05 · accession 0001415889-25-021068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-05 | FENC | Raykov Rosty | Dir | S - Sale | $8.09 | -10.0K | 55.9K | -15% | -$80.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-08-05 | S | D | 10,000 | $8.09 | 55,878 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024. |